artesunic acid has been researched along with Hemorrhagic Fever, Ebola in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dyall, J; Ekins, S; Foil, DH; Goodin, C; Holbrook, MR; Lane, TR; Liang, JY; Madrid, PB; Mercer, L; Postnikova, E; Zhou, H | 1 |
| Ansumana, R; Bangura, H; Boie-Jalloh, M; Idris, M; Jacobsen, KH; Lamin, JM; Sahr, F; Sesay, S | 1 |
2 other study(ies) available for artesunic acid and Hemorrhagic Fever, Ebola
| Article | Year |
|---|---|
Repurposing Pyramax®, quinacrine and tilorone as treatments for Ebola virus disease.
Topics: Antiviral Agents; Artesunate; Drug Combinations; Drug Repositioning; Drug Synergism; Ebolavirus; HeLa Cells; Hemorrhagic Fever, Ebola; Humans; Lysosomes; Machine Learning; MCF-7 Cells; Naphthyridines; Quinacrine; Tilorone; Virus Internalization | 2020 |
Ebola in Freetown area, Sierra Leone--a case study of 581 patients.
Topics: Adolescent; Adult; Anti-Infective Agents; Artemisinins; Artesunate; Ceftriaxone; Child; Combined Modality Therapy; Epidemics; Ethanolamines; Female; Fluid Therapy; Fluorenes; Hemorrhagic Fever, Ebola; Humans; Lumefantrine; Male; Metronidazole; Middle Aged; Sierra Leone; Vitamin K; Young Adult | 2015 |